Recursion Pharmaceuticals
RXRX
#3542
Rank
S$4.17 B
Marketcap
$10.68
Share price
8.18%
Change (1 day)
-27.67%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: S$4.17 Billion

As of January 2025 Recursion Pharmaceuticals has a market cap of S$4.17 Billion. This makes Recursion Pharmaceuticals the world's 3542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2025

End of year Market Cap

Year Marketcap Change
2025S$4.17 B6.35%
2024S$3.92 B39.62%
2023S$2.81 B43.48%
2022S$1.95 B-49.94%
2021S$3.91 B

End of Day market cap according to different sources

On Jan 4th, 2025 the market cap of Recursion Pharmaceuticals was reported to be:

S$3.06 Billion
by Nasdaq info icon info icon
S$4.17 Billion
by CompaniesMarketCap info icon info icon